August 15th 2025
Marguerite B. McDonald, MD, FACS, shares a front-row view of ophthalmology’s “revolution with a capital R."
Aurion Biotech completes dosing of all subjects in Phase 1/2 CLARA trial
May 1st 2024The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of corneal edema secondary to corneal endothelial dysfunction.
Read More
ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
April 16th 2024At this year's ASCRS meeting in Boston, Massachusetts, Ophthalmology Times Europe caught up with Eris Jordan, OD talked about the big plans the Boston-based startup has for the year ahead. Watch the full video to find out what's in store for the company and its novel cell therapy in Japan, Canada and the United States in 2024.
Watch
Possible role of face masks in increased incidence of infectious keratitis after PRK during COVID
April 6th 2024Researchers conducted a retrospective chart review spanning from January 2015 to January 2021 to compare the incidence rates of infectious keratitis before and during the pandemic among PRK patients.
Read More